Diabetes (DM): Clinical Trials

3 trials for Diabetes (DM), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 not yet recruiting. 3 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Recruiting 2, Not yet recruiting 1
Phase 22Not yet recruiting 1, Recruiting 1

Follow Diabetes (DM): new trials by email Literature Review of Diabetes (DM) trials Research Report on Diabetes (DM)

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Studies of Insulin and Glucagon Action in the Liver
Glucagon, Saline (placebo) - Diabetes (DM)
Phase 1 / Phase 2Not yet recruitingDuke University402026-10-012026-08-05
Role of Alpha-to-beta Cell Communication to Adapt Insulin Secretion to Insulin Resistance.
Exendin-9 is a 30 amino acid peptide that is an established competitive antagonist of the GLP-1 receptor. Subjects will receive exendin-9 by intravenous infusion at a rate of 600 pmol/kg/min, Dexamethasone, Dextrose 20% solution - Diabetes (DM)
Phase 1RecruitingDavid D'Alessio, M.D.302025-12-302026-10-01
Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes
Arginine hydrochloride, Sodium Chloride 0.9% - Diabetes (DM), Diabetic Ketoacidosis
Phase 1 / Phase 2RecruitingDavid K Carroll602025-12-192026-02-12

Narrower conditions

Diabetes Mellitus (3)  ·  Insulin Resistance (2)  ·  Diabetes Mellitus, Type 1 (1)  ·  Diabetic Ketoacidosis (1)  ·  Hyperglycemia (1)

Broader conditions

Endocrine System Diseases (3)  ·  Glucose Metabolism Disorders (3)  ·  Metabolic Diseases (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Hyperinsulinism (2)  ·  Acid-Base Imbalance (1)  ·  Acidosis (1)  ·  Autoimmune Diseases (1)  ·  Diabetes Complications (1)  ·  Immune System Diseases (1)  ·  Ketosis (1)

Interventions

Sodium Chloride (2)  ·  Arginine (1)  ·  Dexamethasone (1)  ·  Glucagon (1)  ·  Glucose (1)  ·  Saline Solution (1)  ·  Solutions (1)

Sponsors

David D'Alessio, M.D. (1)  ·  David K Carroll (1)  ·  Duke University (1)

Countries

United States (3)

Top investigators

David D'Alessio, MD (2)

NIH funding

R01DK141090 (1), R01DK142423 (1)